MTIC
FLGT icon

Missouri Trust & Investment Company’s Fulgent Genetics FLGT Stock Holding History

Missouri Trust & Investment Company’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$493 Hold
31
– – ﹤0.01% 398
2025
Q4 		$814 Hold
31
– – ﹤0.01% 386
2025
Q3 		$701 Hold
31
– – ﹤0.01% 394
2025
Q2 		$616 Hold
31
– – ﹤0.01% 406
2025
Q1 		$524 Hold
31
– – ﹤0.01% 398
2024
Q4 		$573 Hold
31
– – ﹤0.01% 413
2024
Q3 		$674 Hold
31
– – ﹤0.01% 373
2024
Q2 		$608 Hold
31
– – ﹤0.01% 380
2024
Q1 		$673 Hold
31
– – ﹤0.01% 385
2023
Q4 		$896 Hold
31
– – ﹤0.01% 396
2023
Q3 		$829 Hold
31
– – ﹤0.01% 394
2023
Q2 		$1.15K Hold
31
– – ﹤0.01% 419
2023
Q1 		$968 Hold
31
– – ﹤0.01% 332
2022
Q4 		$1K Hold
31
– – ﹤0.01% 319
2022
Q3 		$1K Hold
31
– – ﹤0.01% 329
2022
Q2 		$2K Hold
31
– – ﹤0.01% 324
2022
Q1 		$2K Hold
31
– – ﹤0.01% 322
2021
Q4 		$3K Buy
+31
New +$2.73K ﹤0.01% 351

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Missouri Trust & Investment Company's FLGT Position: Q1 2026 in Review

Missouri Trust & Investment Company held its Fulgent Genetics (FLGT) position steady in Q1 2026 at 31 shares worth $493. The position accounts for ﹤0.01% of the portfolio, ranked #398.

Missouri Trust & Investment Company first reported a position in FLGT in Q4 2021 and has held it in 18 quarters since. The position peaked at $3K in Q4 2021. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Missouri Trust & Investment Company held 31 shares of Fulgent Genetics worth $493 as of Q1 2026.
  • Missouri Trust & Investment Company left its Fulgent Genetics share count unchanged in Q1 2026.
  • Fulgent Genetics made up ﹤0.01% of Missouri Trust & Investment Company's portfolio in Q1 2026, its #398 holding.
  • Missouri Trust & Investment Company first reported a position in Fulgent Genetics in Q4 2021 and has held it in 18 quarters since.
  • Missouri Trust & Investment Company's Fulgent Genetics position peaked at $3K in Q4 2021.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Missouri Trust & Investment Company's 13F filing for Q1 2026, filed 14 May 2026.